StockNasdaqGSINCY
Incyte
124,44 $
+2.44 (+2.00%)heute
Valuation & earnings
- P/E ratio
- 15.85
- Forward P/E
- 14
- EPS (ttm)
- $7.85
- Forward EPS
- $8.89
- Price/book
- 3.94
- PEG ratio
- 10.82
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 5.8B
- Revenue growth
- 37.7%
- Profit margin
- 27.71%
- Return on equity
- 30.67%
- Total cash
- 4.5B
- Total debt
- 38.3M
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 1.64 | 2.26 | +38.04% |
| Dec 31, 2025 | 1.92 | 1.8 | -6.08% |
| Mar 31, 2026 | 1.34 | 1.81 | +35.12% |
| Jun 30, 2026 | 2.15 | 3.09 | +43.95% |
Next earnings date: Oct 27, 2026
Analyst view
Consensus ratingBuy28 analysts
Strong buy 2Buy 10Hold 15Sell 1
12-month price targetsImplied upside: +2.65%
86
127.74
155
LowCurrent priceHigh
Latest news
(English)Incyte (INCY) Stock Could Be 34% Above Fair Value After EADV Data
Simply Wall St.Sep 24, 2026
Incyte (INCY) Heads To EADV With New Skin Disease Trial Data
Simply Wall St.Sep 24, 2026
6 ‘Moonshot’ Biotech Stocks That Offer Big Risks, Bigger Rewards
Barrons.comSep 23, 2026
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
BarchartSep 23, 2026
Dow Jones Tech Titan Amazon Eyes Buy Point Amid Battle With Key Support Level
Investor's Business DailySep 22, 2026
Incyte's Colorectal Cancer Program Remains Risky, Long-Term, RBC Says
MT NewswiresSep 22, 2026
Related products
Wie sichtbar ist Incyte in der KI-Suche?
Wir fragen KI-Suchmaschinen live nach Incyte und seinem Markt — und messen, ob und wie prominent die Marke in den Antworten erscheint.
Für Incyte wurde noch kein KI-Sichtbarkeits-Check durchgeführt.
Starten Sie einen Live-Check, um zu sehen, wie KI-Suchmaschinen aktuell über diese Marke sprechen.
Ist Ihre Marke so sichtbar in der KI-Suche?
Aurora überwacht Ihre Marke in 7 KI-Suchmaschinen — Sichtbarkeit, Share of Voice und die Quellen, die KI-Antworten prägen.